GANX - Company ID 0001819411
The table below shows Gain Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $20.84M | $10.39M | $11.79M | $7.31M | $36.88M |
| Short-term investments | - | $5.00M | $5.00M | $12.83M | - |
| Receivables | - | - | - | - | $8.55K |
| Inventory | - | - | - | - | - |
| Total current assets | $22.24M | $11.60M | $17.78M | $21.09M | $37.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $74.92K | $103.62K | $125.96K | $144.38K | $105.99K |
| Goodwill | - | - | - | - | - |
| Total assets | $22.82M | $12.12M | $18.61M | $24.10M | $38.99M |
| Accounts payable | $825.03K | $946.26K | $1.32M | $1.63M | $560.48K |
| Total current liabilities | $3.35M | $3.91M | $4.95M | $4.13M | $2.55M |
| Long-term debt | $300.08K | $328.33K | $449.05K | $495.26K | $590.47K |
| Total liabilities | $4.25M | $4.78M | $6.03M | $5.22M | $4.17M |
| Retained earnings | -$81.19M | -$60.78M | -$38.52M | -$20.93M | -$7.03M |
| Total equity | $18.56M | $7.34M | $12.58M | $18.88M | $34.82M |